Business Wire

Kinaxis Provides Business Update

Share

Kinaxis Inc.® (TSX:KXS) a global leader in end-to-end supply chain orchestration, is today providing an update on its business.

The company today announces that Robert Courteau has been named Executive Chair of Kinaxis, effective immediately, and will serve in this role until a permanent CEO is in place. Kinaxis previously announced that John Sicard will be retiring at the end of 2024, and the search for his successor is well underway. As Executive Chair, Mr. Courteau will continue to work closely with John Sicard and the senior leadership team to drive the company’s strategy until a new CEO is in place.

Kinaxis also announces that Angel Mendez has been appointed Lead Independent Director of the Board of Directors.

The Board of Directors has taken decisive action in recent months to refine Kinaxis’ strategy and execution, including engaging a leading management consultant firm, who has been working with the company on initiatives that Kinaxis will implement to increase value, improve profitability margins and capture even more of the $16B supply chain management software market.

“Kinaxis has positive momentum in its business, has earned a reputation for its vision and innovation, and is working with focus and urgency to take the company to the next level,” said Robert Courteau, Executive Chair. “My focus will be on supporting the management team in driving the company’s strategy forward. The Board continues to engage with longer-term and newer shareholders to elicit their views on the business. I look forward to continuing to work closely with fellow directors and management to ensure that the company is optimally positioned to create growing and sustainable value for shareholders.”

The Board values shareholder feedback and since announcing its CEO succession, Kinaxis leadership has been speaking with shareholders and considering the best approaches going forward. The Board strongly believes that execution of its strategic plan is the best path to maximize shareholder value. The company continues to develop and evaluate its plan and has engaged Goldman Sachs to provide financial advice in this regard.

Kinaxis has a proven track record of success and a reputation for delivering excellence for customers and shareholders. Kinaxis is a market leader in AI with its end-to-end orchestration platform Maestro and is a ten-time Leader in Gartner’s Supply Chain Planning Solutions Magic Quadrant.

About Kinaxis:

Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them, in service of humanity. Our powerful, AI-infused supply chain orchestration platform, Maestro™ combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today’s volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn .

Cautionary Note and Forward-Looking Information

This news release contains forward-looking information within the meaning of Canadian securities legislation. Forward-looking information relates to future events or the anticipated performance of Kinaxis and reflects management’s expectations or beliefs regarding such future events. In certain cases, statements that contain forward-looking information can be identified by the use of words such as “plans”, “expects”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates”, “believes” or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might”, or “will be taken”, “occur” or “be achieved” or the negative of these words or comparable terminology. Forward-looking information in this news release includes statements with respect to Kinaxis’ market share growth plans and goals. By its very nature forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual performance of Kinaxis to be materially different from any anticipated performance expressed or implied by such forward-looking information.

Forward-looking information is subject to a variety of risks and uncertainties, which could cause actual events or results to differ from those reflected in the forward-looking information, including, without limitation, the risks described under the heading “Risk Factors” in the Company’s annual information form dated March 25, 2024 for its fiscal year ended December 31, 2023, under the heading “Forward-Looking Statements” in our news release dated July 31, 2024, and other risks identified in the Company’s filings with Canadian securities regulators, which filings are available on SEDAR+ at https://www.sedarplus.ca.

The risk factors referred to above are not an exhaustive list of the factors that may affect any of the Company’s forward-looking information. Forward-looking information includes statements about the future and is inherently uncertain, and the Company’s actual achievements or other future events or conditions may differ materially from those reflected in the forward-looking information due to a variety of risks, uncertainties and other factors. The Company’s statements containing forward-looking information are based on the beliefs, expectations, and opinions of management on the date the statements are made, and the Company does not assume any obligation to update such forward-looking information if circumstances or management's beliefs, expectations or opinions should change, other than as required by applicable law. For the reasons set forth above, one should not place undue reliance on forward-looking information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240917134209/en/

Contacts

For More Information Contact:

Media Relations
Belinda Thomas | Kinaxis
bthomas@kinaxis.com
+1 613 322 9305

Investor Relations
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com
613-907-7613

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Percona Redefines Cloud-Native Database Management with Percona Everest: the World's First Open Source Public DBaaS Alternative17.9.2024 15:00:00 CEST | Press release

Percona, a global leader in enterprise-grade open source database software and services, today announced that its groundbreaking new database platform, Percona Everest, is now generally available to the public. Percona Everest is an open source, cloud-native database platform designed to deliver similar core capabilities and conveniences provided by database-as-a-service (DBaaS) offerings but without the burden of vendor lock-in and associated challenges. Percona Everest facilitates the work of developers, QA engineers, DevOps engineers, database administrators, and anyone who could benefit from self-serve deployment and management of MySQL, PostgreSQL and MongoDB on Kubernetes. Percona Everest simplifies database management and enables database deployment standardization across multiple clouds and environments. Percona Everest helps enterprises accelerate business operations through its reliable, scalable, and secure cloud-native database infrastructure architecture. “Percona Everest

Orbis Medicines and Vivtex Form Research & Exclusive Licensing Collaboration to Support Orbis Development of Next-Generation Orally Dosable ‘ n Cycles’17.9.2024 14:00:00 CEST | Press release

Orbis Medicines, a leader in oral macrocycle drug discovery, today announced a research collaboration and option to an exclusive license with Vivtex, a biotech company aiming to transform the development of oral biologic therapies for major diseases. The collaboration will enable Orbis to utilize Vivtex’s GI-ORIS™ platform for gut permeability screening to evaluate the oral bioavailability of Orbis’ portfolio of next-generation macrocycle drugs it calls ‘nCycles’. “This collaboration extends our ability to design for oral bioavailability into later stages of preclinical development with Vivtex’s extensively validated ex vivo porcine gut model, which is highly informative for human gut interactions. Our goal is faster development of the highest quality candidates possible for clinical entry as we work towards bringing a new generation of macrocycle drugs to patients,” said Simon Feldbæk, Managing Director and Chief Development Officer at Orbis. Under the agreement, the companies will co

Medidata Recognized as a Leader in Everest Group’s Inaugural Electronic Data Capture PEAK Matrix ® Assessment17.9.2024 14:00:00 CEST | Press release

Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, has been recognized as a Leader in Everest Group‘s first-ever PEAK Matrix® Assessment for Electronic Data Capture (EDC) in life sciences. The report, which evaluated 20 providers, highlighted Medidata Rave EDC for its seamless integration with wearables, sensors, and EHRs, along with its advanced capabilities in source data verification, AI-driven query management, and adverse event handling. Rave EDC earned recognition for its intuitive, low-code design, enabling rapid implementation of protocol amendments, and simplifying the creation of electronic case report forms (eCRFs), while maintaining data quality and integrity for clinical trial sponsors. “We are honored to be recognized as a Leader in EDC by Everest Group,” said Anthony Costello, CEO, Medidata. “Rave EDC, the industry gold standard, has led electronic data capture for decades. Given the constantly evolving

Kaitie Kramer Joins Parse Biosciences as Vice President of Marketing17.9.2024 14:00:00 CEST | Press release

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that Kaitie Kramer has joined the company as vice president of marketing. She will lead the marketing strategy for the company and its growing portfolio of single cell solutions including Evercode™ Whole Transcriptome, Evercode™ TCR, Evercode™ BCR, and CRISPR Detect platforms. “As Parse gains market share in the U.S. and abroad, we’re continuing to hire talented people who can lead us through the next phase of our growth,” noted Parse CEO and co-founder Alex Rosenberg, PhD. “Kaitie’s deep level of experience in this market will be a huge asset for Parse and we’re fortunate to have her as part of our leadership team moving forward.” Kramer brings more than 20 years of commercial biotech experience to the role and joins Parse from Twist Bioscience, where she served as senior director of commercial marketing, overseeing key initiatives to help drive growth and brand awareness

Q4 Expands Presence and Customers in EMEA — Helping More Companies Improve Investor Relations Productivity and Results17.9.2024 14:00:00 CEST | Press release

Q4 Inc. (“Q4” or “the company”), the IR Ops Platform, today announced strong growth and momentum across Europe, the Middle East and Africa (EMEA) — significantly expanding its workforce and customers there. As more businesses in the region tap into the Q4 Platform for investor relations (IR), they’re able to boost efficiency, reduce program execution risks and vastly improve IR outcomes, including enhancing investor relationships and driving premium valuations. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240917555274/en/ Tanya Thomas (Photo: Business Wire) Q4 partners with EMEA businesses including The Adecco Group, Caledonia Mining, Compugen, Voxeljet and many more on the London Stock Exchange, Euronext, Nasdaq Nordic and SIX Swiss Exchange — as well as 2,600+ others around the world, including half of the S&P 500. They use Q4’s powerful, consolidated platform to address comprehensive IR needs: with solutions for IR webs

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye